Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-02-01
著者
-
Hige Shuhei
Department Of Gastroenterology And Hematology Hokkaido University
-
Kumada Hiromitsu
Department Of Gastroenterology Toranomon Hospital
-
Hiramatsu Naoki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Torii Nobuyuki
Department Of Internal Medicine And Gastroenterology Tokyo Women's Medical University
-
Tanaka Eiji
Department Of Digestion And Cardiovascular Medicine University Of Tokushima
-
Imazeki Fumio
Department Of Medicine And Clinical Oncology Graduate School Of Medicine Chiba University
-
Nishiguchi Shuhei
Division Of Hepatobiliary And Pancreatic Disease Department Of Internal Medicine Hyogo College Of Me
-
Karino Yoshiyasu
Department Of Gastroenterology Sapporo Kohsei Hospital
-
Shinkai Noboru
Department Of Clinical Molecular Informative Medicine Nagoya City University Graduate School Of Medi
-
Matsumoto Akihiro
Department Of Cardiothoracic Surgery The University Of Tokyo
-
Tanaka Yasuhito
Department Of Biochemistry And Cell Biology National Institute Of Health
-
Chayama Kazuaki
Programs For Biomedical Research Division Of Frontier Medical Science Department Of Medicine And Mol
-
Saito Masaki
Division Of Hemopoiesis Institute Of Hematology And Department Of Medicine Jichi Medical School
-
Suzuki Yoshiyuki
Department Of Applied Physics Tohoku University
-
Suzuki Yoshiyuki
Department of Hepatology, Toranomon Hospital
-
TORII NOBUYUKI
Department of Internal Medicine and Gastroenterology, Tokyo Women's Medical University
-
SAITO Masaki
Division of Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo College of Medicine
-
KOBAYASHI Mariko
Department of Biomedical Engineering/ND20, Lerner Research Institute, Cleveland Clinic
-
IMAZEKI FUMIO
Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University
-
YOKOSUKA Osamu
Department of Gastroenterology and Clinical Oncology, Graduate School of Medicine, Chiba University
-
TSUGE Masataka
Program for Biomedical Research, Division of Frontier Medical Science, Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University
-
YATSUHASHI Hiroshi
The Clinical Research Center, NHO Nagasaki Medical Center
-
NAGAOKA Shinya
The Clinical Research Center, NHO Nagasaki Medical Center
-
FUJIWARA Kei
Gastroenterology Section, Nagoya Daini Red Cross Hospital
-
KOBAYASHI Mariko
Department of Hepatology, Toranomon Hospital
-
CHAYAMA Kazuaki
Program for Biomedical Research, Division of Frontier Medical Science, Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University
-
SHINKAI Noboru
Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences
-
KARINO Yoshiyasu
Department of Gastroenterology, Sapporo Kosei General Hospital
関連論文
- The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma
- Efficacy and Safety of Combination Therapy of Natural Human Interferon β and Ribavirin in Chronic Hepatitis C Patients with Genotype 2 and High Virus Load
- Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients with Genotype 1b and High Virus Load
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection.
- Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
- The Efficacy of Interferon-beta Monotherapy for Elderly Patients with Type C Hepatitis of Genotype 2
- Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
- Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
- Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients
- The Efficacy of Short-Term Interferon-Beta Therapy for Type C Cirrhotic Patients with Genotype 2a and Low Virus Load
- Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
- Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
- Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
- Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
- Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
- Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
- Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
- Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
- Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
- Factors contributing of ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
- Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
- Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
- Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
- Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation
- Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
- Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
- Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
- Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
- Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection
- Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy
- A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels
- Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
- High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load
- Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
- Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus
- Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan : a retrospective multicenter analysis
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- Hepatitis B virus genotype G is an extremely rare genotype in Japan
- Nucleotide sequences of hepatitis GB virus C. Identification of highly conserved domains in the 5' noncoding region and detection by polymerase chain reaction
- Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis : a multicenter clinical study
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
- Involvement of GBV-C/HGV in liver diseases in Japan
- Clinical features of hepatitis B virus genotype A in Japanese patients
- Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load
- Pulmonary tumor embolism in a case of hepatocellular carcinoma.
- Randomized contolled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C
- Incidence of the appearance of the red color sign on esophageal varices and its predictive factors : long-term observations of 359 patients with cirrhosis
- Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen
- Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
- Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
- Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data
- Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance
- Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course
- Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
- Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
- A Device for Simultaneous Application of Sclerotherapy and Endoscopic Ligation for Management of Esophageal Varices
- Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy
- Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6
- Effect of arterial administration of a high-molecular weight antitumor agent, styrene maleic acid neocarzinostatin, in embolization-resistant liver cancer
- Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon α
- Relationship of hepatocellular carcinogenesis with precore mutant virus and serum hepatitis B virus DNA concentration A longitudinal analysis of patients with cirrhosis
- Detection of Hantaviral Antibodies among Patients with Hepatitis of Unknown Etiology in Japan
- Efficacy of interferon therapy for aged patients with chronic hepatitis C
- Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer - A pilot study
- The Superiority of Laparoscopic Examination in Predicting Hepatocellular Carcinoma after Inteferon Therapy for Chronic Type C Hepatitis
- Hepatitis C virus subtype 3b infection in a hospital Japan: Epidemiological study
- Novel Hepatitis B variants in sibling carriers postitive for antibody to hepatitis B surface antigen
- Usefulness of HCV-RNA counts by the method of HCV-bDNA probe in interferon retreatment for patients with HCV-RNA positive chronic hepatitis C
- A Pilot Study of Thymosin α_1 Therapy for Chronic Hepatitis B Patients
- Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma : a longterm cohort study of 892 patients with viral cirrhosis
- Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load
- Serum levels of γ-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection
- Randomized, controlled trial of natural interferon-α therapy for e-antigen-positive chronic hepatitis B patients
- Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C
- The Development of Chronic Kidney Disease in Japanese Patients with Non-alcoholic Fatty Liver Disease
- Sensitive Assay for Quantification of Hepatitis B Virus Mutants by Use of a Minor Groove Binder Probe and Peptide Nucleic Acids
- Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
- Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks
- Management of hepatitis C ; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
- Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection
- Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease
- Interferon and lamivudine monotherapy on chronic hepatitis B in Japan
- Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan
- New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma
- Psychiatric symptoms related to interferon therapy for chronic hepatitis C : Clinical features and prognosis
- Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C patients
- Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation : A retrospective study of hepatitis C virus-related liver cancer
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients
- Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection.
- Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C
- Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders : Randomized controlled trial
- Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
- Chronic hepatitis B in patients coinfected with human immunodeficiency virus in Japan : a retrospective multicenter analysis